Inflammatory bowel disease risk in patients with axial spondyloarthritis treated with biologic agents: Determined Using the BSRBR-AS and a MetaAnalysis

Gary Macfarlane* (Corresponding Author), R Biallas, LE Dean , GT Jones, Nicola J Goodson, Ovidiu Rotariu

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
7 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Inflammatory bowel disease risk in patients with axial spondyloarthritis treated with biologic agents: Determined Using the BSRBR-AS and a MetaAnalysis'. Together they form a unique fingerprint.

Medicine & Life Sciences